Filter the drugs by their COVID-19 status ,phase of research and how they help

COVID-19 is a respiratory disease caused by the SARS-CoV-2 virus. Browse the database of potential drugs for COVID-19 treatment compiled by the AIM tool.
Substance COVID-19 status Phase of research How it helps Latest publication
n-(1-Adamantyl)-n'-(4-guanidinobenzyl)urea
Potential treatment - theoretical effect Experimental Antiviral Aug/11/2020
Bis(5-amidino-2-benzimidazolyl)methane ketone
Potential treatment - theoretical effect Experimental Antiviral Aug/11/2020
Ethyl 2-[(E)-[[1-[2-[(4-carbamimidoylanilino)methyl]-1-methylbenzimidazol-5-yl]cyclopropyl]-pyridin-2-ylmethylidene]amino]oxyacetate
Potential treatment - theoretical effect Experimental Antiviral Aug/11/2020
Metocurine
Potential treatment - theoretical effect Experimental Antiviral Aug/11/2020
MolPort-000-735-951
Potential treatment - theoretical effect Experimental Antiviral Aug/11/2020
Lifirafenib
Potential treatment - theoretical effect Experimental Antiviral Aug/11/2020
Radotinib
Potential treatment - theoretical effect Experimental Antiviral Aug/11/2020
Proscillaridin
Potential treatment - theoretical effect Natural product Antiviral Aug/11/2020
Tivantinib
Potential treatment - theoretical effect Experimental Antiviral Aug/11/2020
Omipalisib
Potential treatment - pre-clinical evidence Used to treat other disease Antiviral Aug/11/2020
Lonafarnib
Potential treatment - pre-clinical evidence Used to treat other disease Antiviral Aug/11/2020
Pictilisib
Potential treatment - pre-clinical evidence Used to treat other disease Antiviral Aug/11/2020
RO5126766
Potential treatment - pre-clinical evidence Used to treat other disease Antiviral Aug/11/2020
27-hydroxycholesterol
Potential treatment - theoretical effect Natural product Antiviral Aug/10/2020
Narsoplimab
Potential treatment - clinical evidence Used to treat other disease Other treatment Aug/09/2020
Brincidofovir
Potential treatment - theoretical effect Experimental Antiviral Aug/08/2020
1,3,6-trihydroxy-2-methyl-9,10-anthraquinone-3-O-(6′-O-acetyl)-β-D-xylopyranosyl-(1 → 2)-β-D-glucopyranoside
Potential treatment - theoretical effect Experimental Antiviral Aug/08/2020
Torososide B
Potential treatment - theoretical effect Experimental Antiviral Aug/08/2020
Kazinol J
Potential treatment - theoretical effect Natural product Antiviral Aug/07/2020
3′-(3-methylbut-2-enyl)-3′,4′,7-trihydroxyflavane
Potential treatment - theoretical effect Natural product Antiviral Aug/07/2020